Form 4: Tharimmune COO Appajosyula Acquires 5,000 Shares of Common Stock

Sireesh Appajosyula, Chief Operating Officer of Tharimmune, Inc., recently purchased 5,000 shares of the company's common stock at a price of $1.93 per share.

Summary

• On October 8, 2024, Sireesh Appajosyula, the Chief Operating Officer of Tharimmune, Inc., acquired 5,000 shares of common stock.
• The purchase price was $1.93 per share.
• Following the transaction, Appajosyula directly owns 16,364 shares.
• Appajosyula also indirectly owns 38,889 shares through Highpoint Pharmaceuticals, LLC and 304 shares through Channel BioConsulting LLC, where he serves as the managing member.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The COO's purchase of shares is a positive sign, but the document is primarily a regulatory filing.

Positives

• The COO's purchase of shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into a company's performance and future prospects. Purchases by executives are often seen as a positive signal.

Stakeholder Impact

• The COO's purchase may positively influence shareholder sentiment.

Key Dates

Keywords

Tharimmune, Appajosyula, Insider Trading, Form 4, Share Acquisition, Common Stock, COO